Sign in
CompletedNo phase

Investigation of the Relationship Between MD, MLR and NLR With APRs in Sepsis in the ICU

Key facts

Who runs it
Oguz Gundogdu
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
120 people enrolled
Started
1 Oct 2022
Ended
30 Jan 2024
Type of study
Observational, 3 groups
Treatments tested
  • Monocyte Distribution
Record updated
17 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • Patients monitored in the intensive care unit for at least 24 hours
  • Age over 18 years
  • Diagnosis of sepsis or septic shock

Who cannot take part

  • Patients who have undergone organ or bone marrow transplantation
  • Patients receiving immunosuppressive therapy for any reason
  • Patients with hematological diseases
  • Patients with chronic renal failure
  • Patients with liver failure not related to sepsis
  • Patients with intracranial pathologies (e.g., mass, hemorrhage) that may lead to morbidity due to volume loading
  • Patients diagnosed with AIDS
  • Patients admitted due to intoxication

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to investigate, in patients admitted to the intensive care unit either for reasons other than sepsis who subsequently develop sepsis or with a primary diagnosis of sepsis, whether monocyte distribution, monocyte-to-lymphocyte ratio, and neutrophil-to-lymphocyte ratio can be used in addition to conventional biomarkers, and to examine their relationships with these biomarkers.

The 3 groups in the trial

  • Group-I: Control

    Control group - patients over 18 years of age, classified as ASA I-II, with no infection, who applied to the anesthesia outpatient clinic and did not meet any exclusion criteria.

    Treatment: Monocyte Distribution

  • Group-II

    Group II: patients who were admitted to the intensive care unit for reasons other than sepsis and subsequently developed sepsis

    Treatment: Monocyte Distribution

  • Group-III

    Group III: patients admitted to the intensive care unit with a primary diagnosis of sepsis.

    Treatment: Monocyte Distribution

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Investigation of the Relationship Between Monocyte Distribution, Monocyte-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio With Acute Phase Reactants in Sepsis in the Intensive Care Unit
Record updated
17 April 2026